NCT01470859 - The Effect of Pramipexole on Metabolic Network Activity Compared With Levodopa in Early Parkinson's Disease | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions

Idiopathic Parkinson's Disease

Interventions

DRUG

pramipexole

tablets, 0.375mg-4.5mg/day divided by 3 times according to the optimal improvement of motor dysfunction in PD patients. duration is 1 year.

DRUG

Sinemet CR

tablet of Sinemet CR, dosage of levodopa ranging from 200mg-600mg/day divided by 2 or 3 times, Duration is 1 year

Trial Locations (1)

Huashan Hospital Affiliated to Fudan University, Shanghai